Papatheodoridi M. Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in non-cirrhotic HBeAg-negative Chronic Hepatitis B patients: Results from the DARING-B prospective Greek study. PS-159.
Effect van onderbreking methotrexaat op de immuniteit na de COVID-19-booster
jan 2023 | Psoriasis, RA, Vaccinatie, Virale infecties